$2.59 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 134 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $37,549,000 | – | 890,620 | +100.0% | 1.45% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDcall | $31,053,000 | – | 550,000 | +100.0% | 1.20% | – |
| RGNX | New | REGENXBIO INC | $29,444,000 | – | 1,336,542 | +100.0% | 1.14% | – |
| DNAI | New | PRONAI THERAPEUTICS INC | $27,669,000 | – | 1,348,401 | +100.0% | 1.07% | – |
| AKTX | New | AKARI THERAPEUTICS PLCsponsored adr | $27,611,000 | – | 1,150,700 | +100.0% | 1.07% | – |
| MNKKQ | New | MALLINCKRODT PUB LTD CO | $20,329,000 | – | 317,931 | +100.0% | 0.79% | – |
| BKD | New | BROOKDALE SR LIVING INC | $12,789,000 | – | 557,000 | +100.0% | 0.50% | – |
| XNPT | New | XENOPORT INC | $11,955,000 | – | 3,445,374 | +100.0% | 0.46% | – |
| MGNX | New | MACROGENICS INC | $11,931,000 | – | 557,000 | +100.0% | 0.46% | – |
| New | ESSA PHARMA INC | $11,580,000 | – | 1,859,282 | +100.0% | 0.45% | – | |
| ACHN | New | ACHILLION PHARMACEUTICALS IN | $11,519,000 | – | 1,667,000 | +100.0% | 0.45% | – |
| NEOS | New | NEOS THERAPEUTICS INC | $9,630,000 | – | 458,332 | +100.0% | 0.37% | – |
| NVAX | New | NOVAVAX INC | $7,353,000 | – | 1,040,000 | +100.0% | 0.28% | – |
| HTWR | New | HEARTWARE INTL INC | $7,020,000 | – | 134,200 | +100.0% | 0.27% | – |
| EGLTQ | New | EGALET CORP | $6,288,000 | – | 477,123 | +100.0% | 0.24% | – |
| AXGT | New | AXOVANT SCIENCES LTD | $6,262,000 | – | 484,664 | +100.0% | 0.24% | – |
| New | JAZZ INVESTMENTS I LTDnote 1.875% 8/1 | $5,098,000 | – | 5,000,000 | +100.0% | 0.20% | – | |
| PEN | New | PENUMBRA INC | $4,010,000 | – | 100,000 | +100.0% | 0.16% | – |
| BDSI | New | BIODELIVERY SCIENCES INTL IN | $3,892,000 | – | 700,000 | +100.0% | 0.15% | – |
| VSAR | New | VERSARTIS INC | $3,194,000 | – | 277,000 | +100.0% | 0.12% | – |
| ACUR | New | ACURA PHARMACEUTICALS INC | $2,410,000 | – | 1,025,641 | +100.0% | 0.09% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $1,927,000 | – | 18,500 | +100.0% | 0.08% | – |
| ILMN | New | ILLUMINA INC | $1,934,000 | – | 11,000 | +100.0% | 0.08% | – |
| LJPC | New | LA JOLLA PHARMACEUTICAL CO | $1,806,000 | – | 65,000 | +100.0% | 0.07% | – |
| BIIB | New | BIOGEN INC | $1,605,000 | – | 5,500 | +100.0% | 0.06% | – |
| THC | New | TENET HEALTHCARE CORP | $1,019,000 | – | 27,602 | +100.0% | 0.04% | – |
| HALO | New | HALOZYME THERAPEUTICS INC | $676,000 | – | 50,349 | +100.0% | 0.03% | – |
| CAH | New | CARDINAL HEALTH INC | $615,000 | – | 8,000 | +100.0% | 0.02% | – |
| SEM | New | SELECT MED HLDGS CORP | $593,000 | – | 55,000 | +100.0% | 0.02% | – |
| OPHT | New | OPHTHOTECH CORP | $405,000 | – | 10,000 | +100.0% | 0.02% | – |
| VRX | New | VALEANT PHARMACEUTICALS INTL | $281,000 | – | 1,575 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.